Log in

MEDNAX Stock Forecast, Price & News

-0.18 (-1.39 %)
(As of 10/30/2020 12:00 AM ET)
Today's Range
Now: $12.75
50-Day Range
MA: $16.13
52-Week Range
Now: $12.75
Volume750,320 shs
Average Volume1.17 million shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend YieldN/A
MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, pediatric ophthalmology, other newborn pediatric care, and newborn hearing screening program, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. Additionally, it offers consulting services to healthcare facilities and physicians. As of March 12, 2020, the company operated a network of approximately 4,325 physicians. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.51 out of 5 stars

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryHealth Care Services



Sales & Book Value

Annual Sales$3.51 billion
Cash Flow$19.92 per share
Book Value$17.78 per share


Net Income$-1,497,700,000.00


Market Cap$1.09 billion
Next Earnings Date11/6/2020 (Confirmed)
-0.18 (-1.39 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MD News and Ratings via Email

Sign-up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

MEDNAX (NYSE:MD) Frequently Asked Questions

How has MEDNAX's stock been impacted by COVID-19 (Coronavirus)?

MEDNAX's stock was trading at $13.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MD shares have decreased by 8.9% and is now trading at $12.75.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of MEDNAX?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MEDNAX in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for MEDNAX

When is MEDNAX's next earnings date?

MEDNAX is scheduled to release its next quarterly earnings announcement on Friday, November 6th 2020.
View our earnings forecast for MEDNAX

How can I listen to MEDNAX's earnings call?

MEDNAX will be holding an earnings conference call on Friday, November 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were MEDNAX's earnings last quarter?

MEDNAX, Inc. (NYSE:MD) posted its earnings results on Thursday, July, 30th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.34. The company had revenue of $509.20 million for the quarter, compared to analysts' expectations of $590.90 million. MEDNAX had a positive return on equity of 13.86% and a negative net margin of 61.53%.
View MEDNAX's earnings history

What price target have analysts set for MD?

10 analysts have issued 1 year price targets for MEDNAX's stock. Their forecasts range from $12.00 to $33.00. On average, they expect MEDNAX's stock price to reach $19.18 in the next year. This suggests a possible upside of 50.4% from the stock's current price.
View analysts' price targets for MEDNAX

Are investors shorting MEDNAX?

MEDNAX saw a increase in short interest during the month of October. As of October 15th, there was short interest totaling 8,560,000 shares, an increase of 12.8% from the September 30th total of 7,590,000 shares. Based on an average daily volume of 787,300 shares, the short-interest ratio is currently 10.9 days. Approximately 10.4% of the company's shares are sold short.
View MEDNAX's Short Interest

Who are some of MEDNAX's key competitors?

What other stocks do shareholders of MEDNAX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MEDNAX investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), The Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

Who are MEDNAX's key executives?

MEDNAX's management team includes the following people:
  • Dr. Roger J. Medel, Co-Founder & Director (Age 73, Pay $1.92M)
  • Mr. John C. Pepia, Sr. VP & Chief Accounting Officer (Age 57, Pay $574.21k)
  • Mr. Dominic J. Andreano, Exec. VP, Gen. Counsel & Sec. (Age 51, Pay $839.9k)
  • Mr. Mark S. Ordan, CEO & Director (Age 61)
  • Mr. C. Marc Richards, Exec. VP & CFO (Age 49)

What is MEDNAX's stock symbol?

MEDNAX trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

Who are MEDNAX's major shareholders?

MEDNAX's stock is owned by a number of retail and institutional investors. Top institutional investors include LSV Asset Management (1.46%), WINTON GROUP Ltd (0.20%), Robeco Institutional Asset Management B.V. (0.18%), Alberta Investment Management Corp (0.15%), State of New Jersey Common Pension Fund D (0.14%) and Comerica Bank (0.06%). Company insiders that own MEDNAX stock include David A Clark, Dominic J Andreano, John C Pepia, Joseph M Calabro, Md Pascal J Goldschmidt, Michael Fernandez and Nicholas J Nikolopoulos.
View institutional ownership trends for MEDNAX

Which major investors are selling MEDNAX stock?

MD stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Alberta Investment Management Corp, State of New Jersey Common Pension Fund D, Wedge Capital Management L L P NC, New Mexico Educational Retirement Board, LSV Asset Management, New Mexico Educational Retirement Board, and Comerica Bank. Company insiders that have sold MEDNAX company stock in the last year include Md Pascal J Goldschmidt, and Nicholas J Nikolopoulos.
View insider buying and selling activity for MEDNAX

Which major investors are buying MEDNAX stock?

MD stock was bought by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Alpha Windward LLC, Bowling Portfolio Management LLC, BNP Paribas Arbitrage SA, and Nisa Investment Advisors LLC.
View insider buying and selling activity for MEDNAX

How do I buy shares of MEDNAX?

Shares of MD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MEDNAX's stock price today?

One share of MD stock can currently be purchased for approximately $12.75.

How big of a company is MEDNAX?

MEDNAX has a market capitalization of $1.09 billion and generates $3.51 billion in revenue each year. The company earns $-1,497,700,000.00 in net income (profit) each year or $3.14 on an earnings per share basis. MEDNAX employs 5,165 workers across the globe.

What is MEDNAX's official website?

The official website for MEDNAX is www.mednax.com.

How can I contact MEDNAX?

MEDNAX's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The company can be reached via phone at 954-384-0175 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.